Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,786 JPY | -3.44% | -2.82% | +26.92% |
07:18am | Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5% | MT |
Apr. 23 | Shimano’s Attributable Profit Jumps 17.2% in Fiscal Q1 | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.15 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+26.92% | 13.16B | C+ | ||
+0.94% | 76.54B | B | ||
+13.29% | 21.92B | C+ | ||
+38.76% | 8.29B | C+ | ||
+1.47% | 8.05B | B- | ||
+42.87% | 5.09B | C | ||
-2.16% | 2.98B | C+ | ||
+28.96% | 2.35B | C | ||
-5.24% | 1.64B | C | ||
+64.43% | 1.21B | - | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 8697 Stock
- Ratings Japan Exchange Group, Inc.